Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.51−0.02 (-1.31%)
Close on Nov 13, 2026Market cap $850.64KP/E –Yield –
Universe Pharmaceuticals EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$8.06. The highest annual figure on record is $2148.00 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$8.06 | – |
| FY2024 | Sep 30, 2024 | -$626.96 | – |
| FY2023 | Sep 30, 2023 | -$1089.21 | – |
| FY2022 | Sep 30, 2022 | -$1309.11 | -160.9% |
| FY2021 | Sep 30, 2021 | $2148.00 | +27.0% |
| FY2020 | Sep 30, 2020 | $1692.00 | 0.0% |
| FY2019 | Sep 30, 2019 | $1692.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?